International prostate symptom score as a clinical outcome measure for Ethiopian patients with urethral stricture

Ethiopian Medical Journal

Volumn 42, Issue 4, 2004, Pages 277-281

  Lemma, Be Ede ^a   Taye, Mulat ^b   Hawando, Tegene ^b   Bakke, August ^c  

^a Yekatit 12 Hospital Medical College   (Ethiopia)

^b TIKUR ANBESSA HOSPITAL   (Ethiopia)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; ETHIOPIA; HUMAN; INTERNATIONAL COOPERATION; MALE; PATHOPHYSIOLOGY; PROSTATE HYPERTROPHY; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; URETHRA STRICTURE; VALIDATION STUDY;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; ETHIOPIA; HUMANS; INTERNATIONALITY; MALE; PROSTATIC HYPERPLASIA; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; URETHRAL STRICTURE;

EID: 27144541905     PISSN: 00141755     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Ahemed A, Kalayi GD: urethral stricture at Ahmadu Bello university teaching Hospital, Zaira. East Afr. Med. J. 1998;75(10):582-585.
2. Pansadoro V, Emilozzi P. Internal urethrotomy in the management of anterior urethral strictures: Long-term follow up. Urology: 1996; 156:73-75.
3. Morey AF, Mcaninch JW. Sonographic staging of anterior urethral strictures. Urology: 2000; 163: 1070-1075.
4. Badlani GH, Press SM, Defalco A, Oesterling JE, Smith AD: Urolume endourethral prosthesis for the treatment of urethral stricture disease: Long-term results of the North American multicenter urolume trial. Urology 1995; 45(5): 846-856.
5. MacDiarmid SA, Harrigan CT, Cottone J, McIntyre WJ, Johnson E: Assessment of a new transurethral baloon dilatation catheter in the treatment of urethral stricture disease. Urology 2000; 55 (3): 408-413.
6. Epstein RS, Deverka PA, Chute CG, Panser L, Oestrling JE, Michael M. Lieber MM, Schwartz S, Patrick D: Validation of a new quality of life questionnaire for benign prostatic hyperplasia. J Clin Epidemiol: 1992; 45(12): 1431-1445.
7. Lamping DL, Rowe P, Black N and Lessof L: Development and Validation of an audit instrument: the prostate outcome questionnaire. Brit J Urol 1998; 82: 49-62.
8. Barry MJ, fowler FJ, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett ATK and The measurement committee of the American Urological Association: The American urological association symptom index for benign prostatic hyperplasia. J Urol 1992; 148: 1549-1557.
9. Lemma B, Bakke A, Taye M, Hawando T: Validation of the Amharic translation of international prostate symptom score in Ethiopian patients. Ethiop. J. Health Dev. 2001; 15(3): 203-208.
10. Guyatt GH, Bomvarduer C, Tugwell PX. Measuring disease-specific quality of life in clinical trials. CMAJ: 1986: 134; 889-895.